Umana Otto D., Vadakekut Elsa S., Siccardi Marco A.
Cape Fear Valley Hospital, Campbell Unversity
American College of Osteopathic Obstetricians and Gynecologists
The primary objective of antenatal fetal surveillance is to mitigate the risk of stillbirth. For nearly 4 decades, techniques assessing fetal heart rate (FHR) patterns, alongside real-time ultrasonography and umbilical artery Doppler velocimetry, have been used to monitor fetal well-being. These methods are crucial for evaluating the risk of fetal death in pregnancies with preexisting maternal conditions, such as diabetes mellitus, or those complicated by issues such as fetal growth restriction. FHR patterns, activity levels, and muscle tone are indicators that can be affected by hypoxemia and acidemia. When a fetus experiences hypoxemia, blood flow redistribution can lead to reduced renal perfusion and oligohydramnios. Techniques such as cardiotocography, real-time ultrasonography, and monitoring maternal perception of fetal movements are used to detect potential uteroplacental compromise. Identifying fetal compromise allows for intervention before metabolic acidosis can progress to fetal death. However, sudden and severe changes in fetal status, such as placental abruption or umbilical cord accidents, are typically unpredictable and less preventable through these tests. The American College of Obstetricians and Gynecologists (ACOG) has provided general recommendations on when to initiate antenatal fetal surveillance based on the risk of stillbirth; however, strict guidelines have not been established due to the limited amount of evidence-based studies. Consequently, the ACOG encourages antenatal fetal surveillance to be individualized, including initiation, modalities utilized, and frequency, especially in high-risk cases where surveillance might begin at an age where delivery benefits perinatal outcomes. Antenatal fetal surveillance is indicated for conditions with a stillbirth incidence higher than 0.8 per 1000 and a relative risk or odds ratio for stillbirth >2.0 compared to unaffected pregnancies. In the absence of gestational age-adjusted data, ACOG suggests initiating surveillance at 32, 36, or 39 weeks of gestation. Shared decision-making between the patient and clinician is essential, particularly for pregnancies at a high risk of stillbirth or for those with multiple complicating factors. This approach is crucial when dealing with fetal anomalies or initiating surveillance near the threshold of viability, where patient preferences significantly influence care decisions. Various surveillance methods include maternal perception of fetal movement, contraction stress tests (CSTs), nonstress tests (NSTs), biophysical profiles (BPPs), modified BPPs, and umbilical artery Doppler velocimetry. Generally, normal results from these tests are reassuring due to their low false-negative rates. However, antenatal fetal surveillance using any modality may not accurately reflect a significantly affected fetus during acute distress and is less effective at predicting stillbirths resulting from acute maternal-fetal status changes. In addition, some maternal conditions may cause temporary abnormal results during fetal testing that improve as the maternal condition improves. Therefore, abnormal test results should be interpreted within the broader clinical context, with further testing or intervention guided by the overall maternal and fetal condition. In cases of decreased maternal perception of fetal movement, further assessment with NSTs, CSTs, BPPs, or modified BPPs is recommended. Abnormal findings typically lead to additional testing or consideration of delivery. The management of equivocal or abnormal BPP scores varies based on gestational age. For scores of 4 or lower, delivery is often indicated unless the pregnancy is less than 32 weeks, where extended monitoring may be appropriate. Ultimately, abnormal test results necessitate careful evaluation to avoid unnecessary interventions. Continuous intrapartum monitoring is advisable if delivery is attempted. Although fetal kick counting is a simple method to assess fetal well-being, its effectiveness in preventing stillbirth is not well-established and might lead to increased medical interventions.
产前胎儿监测的主要目标是降低死产风险。近40年来,评估胎儿心率(FHR)模式的技术,连同实时超声检查和脐动脉多普勒血流测定法,一直被用于监测胎儿健康状况。这些方法对于评估患有如糖尿病等母体基础疾病的妊娠或那些并发胎儿生长受限等问题的妊娠中的胎儿死亡风险至关重要。FHR模式、活动水平和肌张力是可能受低氧血症和酸血症影响的指标。当胎儿发生低氧血症时,血流重新分布可导致肾灌注减少和羊水过少。诸如胎心监护、实时超声检查以及监测母体对胎儿活动的感知等技术被用于检测潜在的子宫胎盘功能不全。识别胎儿功能不全可在代谢性酸中毒发展至胎儿死亡之前进行干预。然而,胎儿状况的突然严重变化,如胎盘早剥或脐带意外,通常无法预测,且通过这些检查较难预防。美国妇产科医师学会(ACOG)已根据死产风险就何时开始产前胎儿监测提供了一般性建议;然而,由于循证研究数量有限,尚未制定严格的指南。因此,ACOG鼓励产前胎儿监测个体化,包括开始时间、所采用的方式和频率,尤其是在高风险病例中,监测可能在某个孕周开始,此时分娩对围产期结局有益。对于死产发生率高于每1000例0.8例且与未受影响的妊娠相比死产的相对风险或比值比>2.0的情况,建议进行产前胎儿监测。在缺乏根据孕周调整的数据时,ACOG建议在妊娠32、36或39周开始监测。患者与临床医生之间的共同决策至关重要,特别是对于死产风险高的妊娠或那些有多种复杂因素的妊娠。当处理胎儿异常或在生存阈值附近开始监测时,这种方法至关重要,此时患者的偏好会显著影响护理决策。各种监测方法包括母体对胎儿活动的感知、宫缩应激试验(CST)、无应激试验(NST)、生物物理评分(BPP)、改良BPP以及脐动脉多普勒血流测定法。一般来说,这些检查的正常结果因其低假阴性率而令人安心。然而,使用任何方式的产前胎儿监测在急性窘迫期间可能无法准确反映受严重影响的胎儿,并且在预测因急性母婴状况变化导致的死产方面效果较差。此外,一些母体状况可能在胎儿检查期间导致暂时的异常结果,随着母体状况改善而改善。因此,异常检查结果应在更广泛的临床背景下进行解读,并根据母体和胎儿的整体状况进行进一步检查或干预。在母体对胎儿活动的感知减少的情况下,建议用NST、CST、BPP或改良BPP进行进一步评估。异常发现通常会导致进一步检查或考虑分娩。模棱两可或异常的BPP评分的处理根据孕周而异。对于评分4分或更低的情况,通常建议分娩,除非妊娠少于32周,此时延长监测可能是合适的。最终,异常检查结果需要仔细评估以避免不必要的干预。如果尝试分娩,建议进行持续的产时监测。尽管胎动计数是评估胎儿健康状况的一种简单方法,但其在预防死产方面的有效性尚未得到充分证实,并且可能导致医疗干预增加。